BUSINESS● LOWSep 18 · Sep 18, 2026, 2:56 AM
Jazz Pharmaceuticals (JAZZ) Places An $820M Epilepsy Bet
Yahoo Finance · global
Jazz Pharmaceuticals (JAZZ) is making a substantial $820 million investment related to epilepsy. This highlights a significant strategic move by a major pharmaceutical company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS1h agoInflation drives up family expenses by hundreds per month since Jan . 2025mynbc5.com · United StatesBUSINESS1h agoThe Tesla Roadster Should Go Into Production In 2028 , But Dont Get Your Hopes Upengadget.com · Japan